302 related articles for article (PubMed ID: 11522017)
101. Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene.
Mlynarska A; Waszyrowski T; Kasprzak JD
J Thromb Haemost; 2006 Jun; 4(6):1361-6. PubMed ID: 16706983
[TBL] [Abstract][Full Text] [Related]
102. Weight change and blood coagulability and fibrinolysis in healthy obese women.
Rissanen P; Vahtera E; Krusius T; Uusitupa M; Rissanen A
Int J Obes Relat Metab Disord; 2001 Feb; 25(2):212-8. PubMed ID: 11410822
[TBL] [Abstract][Full Text] [Related]
103. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.
Juhan-Vague I; Morange PE; Frere C; Aillaud MF; Alessi MC; Hawe E; Boquist S; Tornvall P; Yudkin JS; Tremoli E; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
J Thromb Haemost; 2003 Nov; 1(11):2322-9. PubMed ID: 14629464
[TBL] [Abstract][Full Text] [Related]
104. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
McCormack LJ; Nagi DK; Stickland MH; Mansfield MW; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetologia; 1996 Dec; 39(12):1512-8. PubMed ID: 8960834
[TBL] [Abstract][Full Text] [Related]
105. Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen.
Brown NJ; Murphey LJ; Srikuma N; Koschachuhanan N; Williams GH; Vaughan DE
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1071-7. PubMed ID: 11397722
[TBL] [Abstract][Full Text] [Related]
106. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
[TBL] [Abstract][Full Text] [Related]
107. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
[TBL] [Abstract][Full Text] [Related]
108. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
109. Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levels.
Juhan-Vague I; Alessi MC; Raccah D; Aillaud MF; Billerey M; Ansaldi J; Philip-Joet C; Vague P
Thromb Haemost; 1992 Jan; 67(1):76-82. PubMed ID: 1615488
[TBL] [Abstract][Full Text] [Related]
110. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
Sudi KM; Gallistl S; Tröbinger M; Payerl D; Weinhandl G; Muntean W; Aigner R; Borkenstein MH
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
[TBL] [Abstract][Full Text] [Related]
111. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
[TBL] [Abstract][Full Text] [Related]
112. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity.
Murakami T; Horigome H; Tanaka K; Nakata Y; Ohkawara K; Katayama Y; Matsui A
Thromb Res; 2007; 119(1):45-53. PubMed ID: 16480759
[TBL] [Abstract][Full Text] [Related]
113. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
[TBL] [Abstract][Full Text] [Related]
114. The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin.
Roncal C; Orbe J; Belzunce M; Rodríguez JA; Páramo JA
J Thromb Haemost; 2006 Aug; 4(8):1798-803. PubMed ID: 16879223
[TBL] [Abstract][Full Text] [Related]
115. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.
Vuckovic BA; Djeric MJ; Tomic BV; Djordjevic VJ; Bajkin BV; Mitic GP
Blood Coagul Fibrinolysis; 2018 Jan; 29(1):19-24. PubMed ID: 28777103
[TBL] [Abstract][Full Text] [Related]
116. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
Juhan-Vague I; Alessi MC
Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
[TBL] [Abstract][Full Text] [Related]
117. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children.
Amato A; Santoro N; Calabrò P; Grandone A; Swinkels DW; Perrone L; del Giudice EM
Int J Obes (Lond); 2010 Dec; 34(12):1772-4. PubMed ID: 20877286
[TBL] [Abstract][Full Text] [Related]
118. In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.
de Lange Z; Rijken DC; Hoekstra T; Conradie KR; Jerling JC; Pieters M
PLoS One; 2013; 8(12):e83151. PubMed ID: 24386152
[TBL] [Abstract][Full Text] [Related]
119. Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study.
Bensen JT; Hsu FC; Brown WM; Sutton BS; Norris JM; Tracy RP; Jenny NS; Saad MF; Haffner S; Bowden DW; Langefeld CD
Hum Hered; 2004; 57(3):128-37. PubMed ID: 15297806
[TBL] [Abstract][Full Text] [Related]
120. Effects of recombinant human erythropoietin on fibrinolytic system in children on continuous ambulatory peritoneal dialysis.
Gündüz Z; Kisaarslan FA; Düsünsel R; Poyrazoglu HM; Saraymen R; Per H
Adv Perit Dial; 1999; 15():278-82. PubMed ID: 10682118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
